Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative LEEP Trial – American Journal of Respiratory and Critical Care Medicine

This is a major study from the American Lung Association Airways Clinical Research Centers focusing on losartan, a drug which could potentially prevent progression of emphysema in people with COPD. However, the results show that losartan did not prevent emphysema progression, which is important for understanding future treatments for COPD patients.